CRGY 8-K Filed 2026-08-03 New authorization

Crescent Energy reports $336M remaining in share repurchase authorization

Energy company maintains opportunistic buyback program under Rule 10b5-1 framework as part of capital allocation strategy

Authorization$2.0B
Remaining$336M
MechanismRule 10b5-1 open-market purcha

What the filing says

Crescent Energy Company disclosed in its Q2 2026 earnings release that its share repurchase program maintains approximately $336 million in remaining authorization as of June 30, 2026. The company's long-standing "all-of-the-above" return of capital framework includes both fixed quarterly dividends and opportunistic share repurchases.

Repurchases may be executed through open-market purchases, privately negotiated transactions, or Rule 10b5-1 trading plans in compliance with securities laws. The timing and execution of any repurchases remain subject to market conditions, contractual limitations, and board discretion. The program is not binding and may be extended, modified, suspended, or discontinued at any time without obligation to repurchase any specific dollar amount or share count.

The disclosure appears in the context of Crescent's strong financial performance in the first half of 2026, which generated record operating cash flow of $707 million and levered free cash flow of $418 million in Q2 alone, supporting both deleveraging and shareholder return activities.

execution
As of June 30, 2026, our share repurchase program (the "Share Repurchase Program") has approximately $336 million of availability remaining. Repurchases of shares of the Company's common stock under the Share Repurchase Program may be made by the Company from time to time in the open market, in a privately negotiated transaction, through purchases made in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, or by such other means as will comply with applicable state and federal securities laws. — Crescent Energy Co 8-K filing  ·  View on SEC EDGAR →

What this means

Crescent's disclosure of $336 million in remaining buyback authority signals the company's continued capacity to repurchase shares as part of its balanced capital allocation strategy alongside fixed dividends ($0.12 per share quarterly) and debt reduction. The company generated substantial free cash flow in the period—$418 million in levered free cash flow in Q2 2026 alone—providing financial flexibility for shareholder returns. However, the filing does not specify the original authorization amount, total shares repurchased to date, or average prices paid, limiting assessment of execution scale relative to the company's market capitalization or historical buyback activity.

Frequently asked questions

What is the current status of Crescent's share repurchase program?
As of June 30, 2026, Crescent has approximately $336 million remaining under its share repurchase authorization. The program operates on an opportunistic basis and is not a binding commitment. The company may execute repurchases through open-market purchases, private negotiations, or Rule 10b5-1 trading plans, subject to market conditions and board discretion.
How does the buyback fit into Crescent's capital allocation framework?
Crescent employs an "all-of-the-above" approach that includes both fixed quarterly dividends and opportunistic share repurchases. In Q2 2026, the board approved a $0.12 per share dividend while maintaining the buyback program. This balanced strategy aims to return capital to shareholders alongside debt reduction and operational reinvestment.
What mechanisms can Crescent use to repurchase shares?
Crescent may repurchase shares through Rule 10b5-1 trading plans, open-market purchases, privately negotiated transactions, or any other method compliant with state and federal securities laws. This flexibility allows the company to execute repurchases in a manner aligned with market conditions and liquidity needs.
Is the repurchase program mandatory or optional?
The program is entirely optional and non-binding. Crescent's board may extend, modify, suspend, or discontinue the program at any time without obligation to repurchase any specific dollar amount or number of shares, ensuring maximum flexibility in capital allocation.
Why did Crescent maintain buyback capacity while redeeming $259 million in debt in Q2 2026?
Crescent generated record operating cash flow of $707 million and levered free cash flow of $418 million in Q2 2026. This strong cash generation enabled the company to simultaneously reduce debt (redeeming $259 million of senior notes due 2029), maintain liquidity (~$2.0 billion pro forma), and preserve buyback optionality for future shareholder returns.
What happens to the unused buyback authorization if the program is discontinued?
If Crescent's board discontinues or suspends the program, any remaining authorization would expire. The company has not disclosed conditions or timelines that would automatically extend or expire the current $336 million authorization, leaving the timing and extent of future repurchases to board discretion.
execution energy-sector rule-10b5-1 opportunistic-buyback capital-allocation cash-flow-driven
Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.